Results 81 to 90 of about 5,941 (192)
Rabeprazole in the treatment of duodenal ulcer desease and functional dyspepsia
Медицинский совет, 2018 The review aims to provide a contemporary view of the pathogenesis and treatment of the most common duodenum diseases – duodenal ulcer disease (DUD) and functional dyspepsia (FD).
V. Yu. Rusyaev +3 more
doaj +1 more source
Rabeprazole: The role of proton pump inhibitors in Helicobacter pylori eradication
, 2005 Proton pump inhibitors have become one of the cornerstones in the treatment of Helicobacter pylori infection. Rabeprazole (Pariet®) is a substituted benzimidazole proton pump inhibitor with potent gastric acid suppression properties.
Sharara A.I.
core +1 more source
Use of Rabeprazol in practice of gastroenterologist
Медицинский совет, 2016 Proton pump inhibitors (PPI) are a class of drugs with the indisputably high effectiveness and a good safety profile. Taking into account the considerable distribution of acid-depending diseases in the modern world PPIs are applied quite widely; the ...
Y. O. Shulpekova
doaj +1 more source
Клинический разбор в общей медицинеDaily pH-impedance monitoring is an effective method for detecting pathologic gastroesophageal refluxes. We would also like to note the value of this method for the diagnosis of refractory gastroesophageal reflux disease (GERD) in the absence of a ...
Tatyana N. Kovalenko +1 more
doaj +1 more source
Rabeprazole is chemically 2- [[[4-(3-
, 2014 Analytical method development and validation for the simultaneous estimation of Rabeprazole sodium and Itopride hydrochloride in bulk and pharmaceutical dosage forms by RP ...
A Kishore Agarwal, Syed Shaheda
core
, 2002 AIM: To compare the antisecretory effects of rabeprazole and esomeprazole in an open, randomized, two-way crossover, clinical pharmacology study. METHODS: Twenty-four healthy subjects (14 men, 10 women; mean age 26.8 years) received rabeprazole 20 mg or ...
Miller, N +5 more
core +1 more source
Gut and Liver, 2010 Background/Aims: Revaprazan, a novel acid-pump antagonist, and proton-pump inhibitors (PPIs) have pH-independent effects on ulcer healing. The addition of a PPI promotes the cell restitution rate as well as vessel regeneration and maturation for ulcer ...
doaj +1 more source
Pharmacology and Clinical Pharmacy ResearchDrugs are a common cause of hyperprolactinemia. They are common in patients taking antipsychotics, antiemetics, opioids, antidepressants, prokinetics and proton pump inhibitors (PPI). Rabeprazole is a relatively newer PPI.
Kiran M, Ananya Chakraborty
doaj +1 more source
Comparative study of Lansoprazole and Rabeprazole on ulcer healing property on albino rats [PDF]
, 2012 Background: Proton pump inhibitors are widely used for gastroesophageal disorders. The present work was carried out to compare effect of lansoprazole & rabeprozole for gastric ulcer healing.
Amit Kumar Jha*
core +2 more sources
The Effect of Rabeprazole on LES Tone in Experimental Rat Model
, 2013 Introduction: Despite adequate treatment with proton pump inhibitors (PPIs), symptoms of gastroesophageal reflux disease (GERD) may remain persistent as well as Barrett's esophagus may emerge.
Polat, Erdal +9 more
core +1 more source